Comparison of the efficacy of in vivo shock therapy with corticosteroid injection in the treatment of piriformis syndrome

Comparison of the efectiveness of Radial Extracorporeal Shock wave Therapy and corticosteroid injection of piriformis muscle for treatment patients suffering of piriformis syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191027045252N1

Enrollment

Registered

2020-01-10

Start date

2019-12-22

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Piriformis syndrome. Lesion of sciatic nerve

Interventions

Intervention 1: Intervention group: Patients undergoing shockwave therapy, three sessions, each lasting 7 to 10 days. Shockwave is performed with the Storz Medical Shock Wave MP100. Each session of sh

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic pain in Batuk, thigh and lower extremity for at least 3 months Patients must be over 20 years of age Screening of all patients for lumbar disc herniation and lumbar radiculopathy by MRI. Their pain intensity should be at least 5 out of 10 according to the Visual Analogue Scale criteria

Exclusion criteria

Exclusion criteria: Symptoms of lumbar discus, coxopathy, mechanical or inflammatory disorders of the sacroiliac joint Any inflammatory, infectious, or pelvic abnormalities Have a pregnancy or pregnancy plan Have a history of disc surgery and any epidural block over the past 6 months. Patients who do not go for follow-up for any reason. Changes in the patient's treatment according to the physician's opinion or other treatment by the patient during the study

Design outcomes

Primary

Measure	Time frame
Severity of pain. Timepoint: Baseline, 7, 30, 60, and 90 days after Intervention. Method of measurement: Visual Analogue Scale.;Quality of Life. Timepoint: Baseline and 30 days after Intervention. Method of measurement: 36-Item Short Form Survey (SF-36) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Babaei

Iran University of Medical Sciences

arastoo.yousefi@gmail.com+98 21 2235 9437

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026